Results of a phase II study involving Abexinostat in relapsed CLL and Non-Hodgkin
Home / Resource Library / Safety And Efficacy Of Abexinostat, A Pan-Histone Deacetylase Inhibitor, In Non-Hodgkin Lymphoma And Chronic Lymphocytic Leukemia
Results of a phase II study involving Abexinostat in relapsed CLL and Non-Hodgkin